Bipolar Disorder Management

Diagnosis and Symptoms

Symptoms of agitation, rapid speech, and manic behavior most likely represent bipolar disorder, characterized by elevated, expansive, or irritable mood, grandiosity, decreased need for sleep, pressured/rapid speech, racing thoughts, distractibility, increased goal-directed activity, psychomotor agitation, and excessive involvement in risky activities, requiring mood stabilizers, atypical antipsychotics, or benzodiazepines for acute management 1
Bipolar NOS is characterized by manic symptoms lasting hours to less than 4 days or chronic manic-like symptoms 1

Combination therapy is most effective for acute severe agitation: benzodiazepine plus antipsychotic, with lorazepam 2-4 mg + haloperidol 5 mg IM/PO showing superior efficacy compared to either medication alone 2
Midazolam 5 mg IM provides more rapid sedation (average 18.3 minutes) compared to lorazepam (32.2 minutes) or haloperidol (28.3 minutes) 2
A combination of a benzodiazepine (lorazepam) and an antipsychotic is frequently recommended for acute severe agitation with mood swings, due to its rapid onset of action and efficacy 3

The American Academy of Child and Adolescent Psychiatry recommends lithium or valproate as first-line treatment for classic manic presentation, with valproate often preferred for rapid cycling 1
Atypical antipsychotics, such as risperidone, olanzapine, and quetiapine, are effective options for psychotic features, agitation with anxiety, and sleep disturbance, with specific dosage recommendations: risperidone (0.25 mg/day at bedtime, max 2-3 mg/day), olanzapine (2.5 mg/day at bedtime, max 10 mg/day), and quetiapine (12.5 mg twice daily, max 200 mg twice daily) 1, 4
Lithium is FDA-approved for patients aged 12 and above for acute mania and maintenance therapy, and is often considered first-line for bipolar disorder with classic presentations 1
Valproate (Depakote) is generally better tolerated than other mood stabilizers, with a starting dose of 125 mg twice daily, titrated to a therapeutic blood level (40-90 mcg/mL) 4
Lamotrigine is FDA-approved for maintenance therapy in adults with bipolar disorder, and is particularly effective for bipolar depression and prevention of depressive episodes 1

Medication regimen needed to stabilize acute symptoms should be maintained for 12-24 months to prevent relapse, with regular monitoring of blood levels, liver enzymes, platelets, and metabolic side effects 1, 5
Most patients require ongoing medication therapy, with some needing lifelong treatment, and comorbid anxiety and substance use disorders should be addressed 1, 5
Regular monitoring is required for lithium (blood levels), valproate (liver enzymes, platelets, and blood levels), and atypical antipsychotics (metabolic side effects) 1, 4
Antidepressants should only be used as adjuncts for depression when the patient is also taking at least one mood stabilizer, as they may trigger manic episodes 1, 5

Children and adolescents: Lithium is FDA-approved for patients aged 12 and above, but the safety profile of other agents in young children has not been well established 1
The American Academy of Child and Adolescent Psychiatry recommends that medication choice should be based on evidence of efficacy, phase of illness, presence of confounding presentations, side effect profile, patient's history of medication response, and medication safety profile 1
Bupropion is not recommended for newly diagnosed bipolar patients due to its high risk of triggering manic episodes, and should be avoided in initial treatment 1
In patients with anxiety, quetiapine or valproate may be particularly helpful, while in patients with sleep disturbance, more sedating options like quetiapine may be beneficial 4